Patients harboring epidermal growth factor receptor (EGFR) double mutations had a lower objective response rate than those with a single mutation in non-small cell lung cancer when treated with EGFR-tyrosine kinase inhibitors.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zhigang,Wei

第一单位： Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Medical Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute Beijing, China.

作者： Zhigang,Wei ^[1] ; Tongtong,An ^[1] ; Zhijie,Wang ^[1] ; Keneng,Chen ^[2] ; Hua,Bai ^[1] ; Guangying,Zhu ^[3] ; Jianchun,Duan ^[1] ; Meina,Wu ^[1] ; Lu,Yang ^[1] ; Minglei,Zhuo ^[1] ; Yuyan,Wang ^[1] ; Xuyi,Liu ^[1] ; Jie,Wang ^[1]

作者单位： Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Medical Oncology, Peking University School of Oncology, Beijing Cancer Hospital & Institute Beijing, China. ^[1] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery, Peking University School of Oncology, Beijing Cancer Hospital & Institute Beijing, China. ^[2] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiology, Peking University School of Oncology, Beijing Cancer Hospital & Institute Beijing, China. ^[3]

关键词 DHPLC double mutations epidermal growth factor receptor lung neoplasms tyrosine kinase inhibitor

DOI 10.1111/1759-7714.12068

PMID 26766989

发布时间 2018-11-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览32

Thoracic cancer

2014年5卷2期

126-32页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Patients harboring epidermal growth factor receptor (EGFR) double mutations had a lower objective response rate than those with a single mutation in non-small cell lung cancer when treated with EGFR-tyrosine kinase inhibitors.

Thoracic cancer

相似文献

Thoracic cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Patients harboring epidermal growth factor receptor (EGFR) double mutations had a lower objective response rate than those with a single mutation in non-small cell lung cancer when treated with EGFR-tyrosine kinase inhibitors.

Thoracic cancer

相似文献

Thoracic cancer

相关期刊

检索历史清除